Literature DB >> 2372940

Methylmalonic acid concentrations in serum of normal subjects: biological variability and effect of oral L-isoleucine loads before and after intramuscular administration of cobalamin.

K Rasmussen1, J Møller, K Ostergaard, M O Kristensen, J Jensen.   

Abstract

The clinical value of measuring concentrations of methylmalonic acid in serum (S-MMA) as an aid in the diagnosis of cobalamin deficiency has recently aroused interest. In 58 healthy subjects, ages 40-68 years, we found a 0.95 reference interval of 0.05-0.37 mumol/L (mean 0.21, SD 0.094). In 33 of the subjects, who were studied further, day-to-day variation (SD) was 0.031 mumol/L. Intake of food had no effect. Weekly and three-monthly intra-individual variations were both 0.038 mumol/L. In all seven subjects with S-MMA greater than 0.30 mumol/L, the concentrations declined significantly after intramuscular administration of cobalamin. No significant difference was found between mean serum cobalamin concentrations in these seven and in the remaining subjects. We have also established the normal response of S-MMA to standardized oral loading of L-isoleucine: 100 mmol caused a significant average S-MMA increase of 0.072 mumol/L before cobalamin administration vs 0.013 mumol/L after cobalamin, without significant relation to initial S-MMA values. Our results provide a necessary background for interpretation of S-MMA measurements in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372940

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Age-specific reference ranges are needed to interpret serum methylmalonic acid concentrations in the US population.

Authors:  Ekaterina M Mineva; Maya R Sternberg; Mindy Zhang; Yutaka Aoki; Renee Storandt; Regan L Bailey; Christine M Pfeiffer
Journal:  Am J Clin Nutr       Date:  2019-07-01       Impact factor: 7.045

2.  A Common Polymorphism in HIBCH Influences Methylmalonic Acid Concentrations in Blood Independently of Cobalamin.

Authors:  Anne M Molloy; Faith Pangilinan; James L Mills; Barry Shane; Mary B O'Neill; David M McGaughey; Aneliya Velkova; Hatice Ozel Abaan; Per M Ueland; Helene McNulty; Mary Ward; J J Strain; Conal Cunningham; Miriam Casey; Cheryl D Cropp; Yoonhee Kim; Joan E Bailey-Wilson; Alexander F Wilson; Lawrence C Brody
Journal:  Am J Hum Genet       Date:  2016-04-28       Impact factor: 11.025

3.  Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial.

Authors:  Bernard Favrat; Paul Vaucher; Lilli Herzig; Bernard Burnand; Giuseppa Ali; Olivier Boulat; Thomas Bischoff; François Verdon
Journal:  BMC Fam Pract       Date:  2011-01-13       Impact factor: 2.497

4.  South Asian Ethnicity Is Related to the Highest Risk of Vitamin B12 Deficiency in Pregnant Canadian Women.

Authors:  Marta Jeruszka-Bielak; Carly Isman; Theresa H Schroder; Wangyang Li; Tim J Green; Yvonne Lamers
Journal:  Nutrients       Date:  2017-03-23       Impact factor: 5.717

5.  Effect of 8-week oral supplementation with 3-µg cyano-B12 or hydroxo-B12 in a vitamin B12-deficient population.

Authors:  Eva Greibe; Namita Mahalle; Vijayshri Bhide; Sergey Fedosov; Christian W Heegaard; Sadanand Naik; Ebba Nexo
Journal:  Eur J Nutr       Date:  2017-12-05       Impact factor: 5.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.